Zacks Investment Research on MSN4h
AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication
Amgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The ...